Marijuana might still be illegal at the federal level in the U.S. But 33 states now allow the legal use of medical cannabis, and 10 states have legal adult-use recreational marijuana markets. It’s not surprising that the U.S. claims the world’s largest marijuana market. Two publicly traded companies that have made their marks in this big market are Green Thumb Industries (NASDAQOTH:GTBIF) and KushCo Holdings (NASDAQOTH:KSHB).
Green Thumb Industries (GTI) has been the bigger winner so far in 2019, with its stock soaring close to 80%. KushCo is up by only a few percentage points year to date. However, past performance isn’t very important when evaluating how stocks might perform in the future.
Which of these two marijuana stocks is the better pick for long-term investors now? Here’s what you need to know about Green Thumb Industries and KushCo Holdings….
The case for Green Thumb Industries
When billionaire investor Leon Cooperman decided to dip his toes into investing in the cannabis industry last year, Green Thumb Industries was one of the three stocks he bought. There are several factors that likely made GTI stand out for Cooperman then and are applicable for investors considering the stock today.
Perhaps the most impressive achievement for GTI is the scope of operations the company has built. As of March, GTI conducted business in 11 states. But with its pending acquisitions, that total will increase to 12 states.
These states include several of the strongest cannabis markets in the U.S. California is already the biggest legal marijuana market in the world. Florida and Massachusetts are likely on track to have annual cannabis sales of more than $1 billion by 2022. Three large states with medical cannabis markets in which GTI currently operates could be on their way to legalizing recreational pot as well — Illinois, New Jersey, and New York.
GTI grows and produces cannabis in its 13 facilities. The company also is a major cannabis retailer, with 18 stores already open and licenses for another 70 retail locations.
Cannabidiol (CBD) products present another growth opportunity for GTI. The company recently launched a line of CBD-infused skincare products under the brand Beboe Therapies. These products will be carried in upscale retailers including Barneys New York and Neiman Marcus.
In its latest quarter, GTI reported revenue of $20.8 million, up 237% year over year and 21% quarter over quarter. The company isn’t yet profitable, but it’s still investing heavily in expansion. As U.S. cannabis and CBD product markets continue to grow, it seems likely that GTI could become quite profitable.
The case for KushCo Holdings
KushCo Holdings ranks as…
Continue reading at THE MOTLEY FOOL
